These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17581309)

  • 1. The efficiency of a PAMAM dendrimer toward the encapsulation of the antileukemic drug 6-mercaptopurine.
    Neerman MF
    Anticancer Drugs; 2007 Aug; 18(7):839-42. PubMed ID: 17581309
    [No Abstract]   [Full Text] [Related]  

  • 2. The development of folate-PAMAM dendrimer conjugates for targeted delivery of anti-arthritic drugs and their pharmacokinetics and biodistribution in arthritic rats.
    Chandrasekar D; Sistla R; Ahmad FJ; Khar RK; Diwan PV
    Biomaterials; 2007 Jan; 28(3):504-12. PubMed ID: 16996126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAMAM dendrimers and model membranes: differential scanning calorimetry studies.
    Klajnert B; Epand RM
    Int J Pharm; 2005 Nov; 305(1-2):154-66. PubMed ID: 16214300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular interactions between dimethoxycurcumin and Pamam dendrimer carriers.
    Markatou E; Gionis V; Chryssikos GD; Hatziantoniou S; Georgopoulos A; Demetzos C
    Int J Pharm; 2007 Jul; 339(1-2):231-6. PubMed ID: 17428628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of dendrimers and drug-dendrimer conjugates for drug delivery.
    Najlah M; D'Emanuele A
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):756-67. PubMed ID: 17987527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of poly(amidoamine) (PAMAM) dendrimer on skin permeation of 5-fluorouracil.
    Venuganti VV; Perumal OP
    Int J Pharm; 2008 Sep; 361(1-2):230-8. PubMed ID: 18582550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External electrostatic interaction versus internal encapsulation between cationic dendrimers and negatively charged drugs: which contributes more to solubility enhancement of the drugs?
    Cheng Y; Wu Q; Li Y; Xu T
    J Phys Chem B; 2008 Jul; 112(30):8884-90. PubMed ID: 18605754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of poly(amidoamine) dendrimers as drug carriers of camptothecin based on encapsulation studies.
    Cheng Y; Li M; Xu T
    Eur J Med Chem; 2008 Aug; 43(8):1791-5. PubMed ID: 18215444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dendrimer on entrapment and release of bioactive from liposomes.
    Khopade AJ; Caruso F; Tripathi P; Nagaich S; Jain NK
    Int J Pharm; 2002 Jan; 232(1-2):157-62. PubMed ID: 11790499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing amine terminals in an amine-deprived collagen matrix.
    Tiong WH; Damodaran G; Naik H; Kelly JL; Pandit A
    Langmuir; 2008 Oct; 24(20):11752-61. PubMed ID: 18774827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting cancer cells with biotin-dendrimer conjugates.
    Yang W; Cheng Y; Xu T; Wang X; Wen LP
    Eur J Med Chem; 2009 Feb; 44(2):862-8. PubMed ID: 18550227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotinylated poly(amido)amine (PAMAM) dendrimers as carriers for drug delivery to ovarian cancer cells in vitro.
    Yellepeddi VK; Kumar A; Palakurthi S
    Anticancer Res; 2009 Aug; 29(8):2933-43. PubMed ID: 19661298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The stability of 6-mercaptopurine riboside in neutral and basic medium.
    Jelińska A; Magdziarz M
    Acta Pol Pharm; 2000; 57(6):407-9. PubMed ID: 11243244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anionic PAMAM dendrimers as drug delivery vehicles for transition metal-based anticancer drugs.
    Pisani MJ; Wheate NJ; Keene FR; Aldrich-Wright JR; Collins JG
    J Inorg Biochem; 2009 Mar; 103(3):373-80. PubMed ID: 19121543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Layer-by-layer assembled thin films composed of carboxyl-terminated poly(amidoamine) dendrimer as a pH-sensitive nano-device.
    Tomita S; Sato K; Anzai J
    J Colloid Interface Sci; 2008 Oct; 326(1):35-40. PubMed ID: 18649890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, characterization and stability of a luteinizing hormone-releasing hormone (LHRH)-functionalized poly(amidoamine) dendrimer conjugate.
    Bi X; Shi X; Baker JR
    J Biomater Sci Polym Ed; 2008; 19(1):131-42. PubMed ID: 18177559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved pharmacokinetics of mercaptopurine afforded by a thermally robust hemihydrate.
    Kersten KM; Matzger AJ
    Chem Commun (Camb); 2016 Apr; 52(30):5281-4. PubMed ID: 27002860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Composition of topical drugs].
    Zerrouk N; Arnaud P
    Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S27-9. PubMed ID: 17563711
    [No Abstract]   [Full Text] [Related]  

  • 19. PAMAM-triamcinolone acetonide conjugate as a nucleus-targeting gene carrier for enhanced transfer activity.
    Ma K; Hu MX; Qi Y; Zou JH; Qiu LY; Jin Y; Ying XY; Sun HY
    Biomaterials; 2009 Oct; 30(30):6109-18. PubMed ID: 19656564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy.
    Lai PS; Lou PJ; Peng CL; Pai CL; Yen WN; Huang MY; Young TH; Shieh MJ
    J Control Release; 2007 Sep; 122(1):39-46. PubMed ID: 17628166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.